Cargando…
Design and Development of a Behaviorally Active Recombinant Neurotrophic Factor
INTRODUCTION: Carbamoylated erythropoietin (CEPO) is a chemically engineered, nonhematopoietic derivative of erythropoietin (EPO) that retains its antidepressant and pro-cognitive effects, which are attributed to the increased expression of neurotrophic factors like brain derived neurotrophic factor...
Autores principales: | Pekas, Nicholas J, Petersen, Jason L, Sathyanesan, Monica, Newton, Samuel S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723032/ https://www.ncbi.nlm.nih.gov/pubmed/33304094 http://dx.doi.org/10.2147/DDDT.S274308 |
Ejemplares similares
-
Antidepressant-like effects of trophic factor receptor signaling
por: Sathyanesan, Monica, et al.
Publicado: (2022) -
Synergism of Carbamoylated Erythropoietin and Insulin-like Growth Factor-1 in Immediate Early Gene Expression
por: Rothschadl, Morgan J., et al.
Publicado: (2023) -
Computational analysis of ligand–receptor interactions in wild-type and mutant erythropoietin complexes
por: Pekas, Nicholas J, et al.
Publicado: (2018) -
Erythropoietin and Non-Erythropoietic Derivatives in Cognition
por: Newton, Samuel S., et al.
Publicado: (2021) -
Cognitive dysfunction in major depression and Alzheimer’s disease is associated with hippocampal–prefrontal cortex dysconnectivity
por: Sampath, Dayalan, et al.
Publicado: (2017)